Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Ibere Pharmaceuticals (IBER-UN)

    Price:

    10.16 USD

    ( - 0 USD)

    Your position:

    0 USD

    No data to display

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    IBER-UN
    Name
    Ibere Pharmaceuticals
    Industry
    Shell Companies
    Sector
    Financial Services
    Price
    10.160
    Market Cap
    0
    Enterprise value
    111.263M
    Currency
    USD
    Ceo
    Osagie O. Imasogie
    Full Time Employees
    Ipo Date
    City
    Philadelphia
    Address
    2005 Market Street

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Lucid Group, Inc.

    VALUE SCORE:

    0

    Symbol
    CCIV
    Market Cap
    44.388B
    Industry
    Shell Companies
    Sector
    Financial Services

    2nd position

    Jackson Acquisition Company II

    VALUE SCORE:

    8

    Symbol
    JACS-UN
    Market Cap
    307.736M
    Industry
    Shell Companies
    Sector
    Financial Services

    The best

    Jackson Acquisition Company II

    VALUE SCORE:

    8

    Symbol
    JACS
    Market Cap
    307.736M
    Industry
    Shell Companies
    Sector
    Financial Services
    FUNDAMENTALS
    P/E
    74.910
    P/S
    0
    P/B
    0.920
    Debt/Equity
    0
    EV/FCF
    -201.609
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0
    Earnings yield
    0.013
    Debt/assets
    0
    FUNDAMENTALS
    Net debt/ebidta
    0.129
    Interest coverage
    0
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    0
    Capex to revenue
    0
    Capex to depreciation
    0
    Return on tangible assets
    0.011
    Debt to market cap
    0
    Piotroski Score
    FUNDAMENTALS
    PEG
    0.749
    P/CF
    -134.687
    P/FCF
    -202.136
    RoA %
    1.126
    RoIC %
    -0.726
    Gross Profit Margin %
    0
    Quick Ratio
    1.862
    Current Ratio
    1.862
    Net Profit Margin %
    0
    Net-Net
    -0.964
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.076
    Revenue per share
    0
    Net income per share
    0.136
    Operating cash flow per share
    -0.076
    Free cash flow per share
    -0.076
    Cash per share
    0.040
    Book value per share
    11.064
    Tangible book value per share
    11.064
    Shareholders equity per share
    11.064
    Interest debt per share
    0
    TECHNICAL
    52 weeks high
    10.370
    52 weeks low
    9.800
    Current trading session High
    10.160
    Current trading session Low
    10.160
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

    NEWS